Major Morbidities and Risk Factors for Mortality among Very Preterm Infants

Authors

  • Woruttirat Tangsakul Pediatrician, Professional Level, Pediatrics Department, Chaiyaphum Hospital

Keywords:

gestational age, major morbidity, mortality, risk factors, very preterm infant

Abstract

            Preterm birth is the leading cause of neonatal mortality, particularly in infants born before 32 weeks of gestation who are at high risk for severe complications. This study aimed to determine the prevalence of major morbidities and risk factors for mortality in very preterm infants. A retrospective cohort study using retrospective data was conducted among infants born at less than 32 weeks of gestation at Chaiyaphum Hospital between January 2022 and August 2025. The dependent variable was in-hospital mortality, while independent variables included infant and maternal characteristics. Data were collected from electronic medical records and analyzed using descriptive statistics and logistic regression, survival analysis by Kaplan-Meier curve.

            Of 159 infants enrolled, 81.8% survived and 18.2% died. Median gestational age was 30.0 weeks and median birth weight was 1,380 grams. Non-survivors had significantly lower gestational age and birth weight than survivors (p <0.001). Among survivors, the prevalence of bronchopulmonary dysplasia was 30.0% and treated retinopathy of prematurity was 23.8%, with 57.7% surviving without major morbidities. Multivariable analysis revealed gestational age less than 28 weeks as the most significant independent risk factor (ORAdjusted 9.18; 95% CI: 1.81, 46.53). The prediction model showed excellent discrimination (AUC 0.916).

            In conclusion, gestational age is the most important predictor of mortality in very preterm infants. Increasing antenatal corticosteroid coverage and developing strategies to prevent major morbidities in high-risk infants are recommended.

References

Ohuma EO, Moller AB, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet 2023;402(10409):1261-71. DOI:10.1016/S0140-6736(23)00878-4

Bradley E, Blencowe H, Moller AB, Okwaraji YB, Sadler F, Gruending A, et al. Born too soon: global epidemiology of preterm birth and drivers for change. Reprod Health 2025;22(Suppl 2):105. DOI:10.1186/s12978-025-02033-x

World Health Organization. "Healthy Beginnings, Hopeful Futures": Thailand Marks World Health Day 2025 with Commitment to Strengthen Care for Preterm Infants. [Internet]. 2025. [cited 2025 Nov 21]. Available from:

https://www.who.int/thailand/news/detail/23-04-2025-thailand-marks-world-health-day-2025-with-commitment-to-strengthen-care-for-preterm-infants

Neonatal mortality rate and burden of disease in Thai neonates: A nationwide data analysis. Sciety; 2024 Aug 27. DOI:https://doi.org/10. 21203/rs.3.rs-4798791/v1

Kiatchoosakun P, Jirapradittha J, Paopongsawan P, Techasatian L, Lumbiganon P, Thepsuthammarat K, et al. Mortality and Comorbidities in Extremely Low Birth Weight Thai Infants: A Nationwide Data Analysis. Children (Basel) 2022;9(12):1825. DOI:10.3390/children9121825

Konzett K, Riedl D, Blassnig-Ezehm A, Gang S, Simma B. Outcome in very preterm infants: a population-based study from a regional center in Austria. Front Pediatr 2024;12:1336469. DOI:10.3389/fped.2024.1336469

Kong XY, Xu FD, Wu R, Wu H, Ju R, Zhao X, et al. Neonatal mortality and morbidity among infants between 24 to 31 complete weeks: a multicenter survey in China from 2013 to 2014. BMC Pediatr 2016;16(1):174. DOI:10.1186/s12887-016-0716-5

Cao G, Liu J, Liu M. Global, regional, and national incidence and mortality of neonatal preterm birth, 1990-2019. JAMA Pediatr 2022;176(8):787-96. DOI:10.1001/jamapediatrics.2022.1622

Sililert S, Tongsong T. Response: Impacts of β-thalassemia/hemoglobin E disease on fetal growth restriction and preterm birth. Int J Gynecol Obstet 2024;166(1):465-7. DOI:10.1002/ijgo.15589

Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007;165(6):710-8. DOI:10.1093/aje/kwk052

Zhu Z, Yuan L, Wang J, Li Q, Yang C, Gao X, et al. Mortality and Morbidity of Infants Born Extremely Preterm at Tertiary Medical Centers in China From 2010 to 2019. JAMA Netw Open 2021;4(5):e219382. DOI:10.1001/jamanetworkopen.2021.9382

ณัฐวรรณ สวงโท. ปัจจัยเสี่ยงที่มีผลต่อภาวะหายใจเร็วชั่วคราวของทารกแรกเกิดในโรงพยาบาลชัยภูมิ. ชัยภูมิเวชสาร 2563;40(1):89-96. https://thaidj.org/index. php/CMJ/article/view/8879

Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017;3(3):CD004454. DOI:10.1002/14651858.CD004454.pub3

Vogel JP, Ramson J, Darmstadt GL, Qureshi ZP, Chou D, Bahl R, et al. Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. Lancet Glob Health 2022;10(12):e1707-8. DOI:10.1016/S2214-109X(22)00434-X

Pattanittum P, Ewens MR, Laopaiboon M, Lumbiganon P, McDonald SJ, Crowther CA, ; SEA-ORCHID Study Group. Use of antenatal corticosteroids prior to preterm birth in four South East Asian countries within the SEA-ORCHID project. BMC Pregnancy Childbirth 2008;8:47. DOI:10.1186/1471-2393-8-47

Chang HP, Lien R, Chu SM, Lin JJ, Chiang MC. Outcomes of and factors associated with the development of bronchopulmonary dysplasia with pulmonary hypertension in very low birth weight infants. Front Pediatr 2023;11:1055439. DOI:10.3389/fped.2023.1055439

Published

2026-02-23

Issue

Section

Original Article